Ten-year all-cause mortality according to smoking status in patients with severe coronary artery disease undergoing surgical or percutaneous revascularization

Autor: David R. Holmes, Piroze M. Davierwala, Kuniaki Takahashi, Stuart J. Head, Robbert J. de Winter, Masafumi Ono, Milan Milojevic, Marie-Claude Morice, Michael J. Mack, Daniel J F M Thuijs, Joanna J. Wykrzykowska, Friedrich-Wilhelm Mohr, John W. McEvoy, Yoshinobu Onuma, Nick Curzen, Arie Pieter Kappetein, Keith D. Dawkins, Chao Gao, Patrick W. Serruys

Publikováno v: European Journal of Preventive Cardiology, 29(2), 312-320
European Journal of Preventive Cardiology, 29, 312-320
European journal of preventive cardiology, 29(2), 312-320. SAGE Publications Ltd
European Journal of Preventive Cardiology, 29, 2, pp. 312-320
European journal of preventive cardiology, 29(2), 312-320. SAGE Publications Inc.

Aims To evaluate the impact of various smoking status on 10-year all-cause mortality and to examine a relative treatment benefit of coronary artery bypass grafting (CABG) vs. percutaneous coronary intervention (PCI) according to smoking habits. Metho

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2a1d840f5b851f78cca3705a196b6a3
https://doi.org/10.1093/eurjpc/zwaa089

Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial

Autor: Daniel J F M Thuijs, A Pieter Kappetein, Patrick W Serruys, Friedrich-Wilhelm Mohr, Marie-Claude Morice, Michael J Mack, David R Holmes, Nick Curzen, Piroze Davierwala, Thilo Noack, Milan Milojevic, Keith D Dawkins, Bruno R da Costa, Peter Jüni, Stuart J Head, Filip Casselman, Bernard de Bruyne, Evald Høj Christiansen, Juan M. Ruiz-Nodar, Paul Vermeersch, Werner Schultz, Manel Sabaté, Giulio Guagliumi, Herko Grubitzsch, Karl Stangl, Olivier Darremont, M. Bentala, Peter den Heijer, Istvan Preda, Robert Stoler, Michael J. Mack, Tamás Szerafin, John K. Buckner, Myles S. Guber, Niels Verberkmoes, Ferdi Akca, Ted Feldman, Friedhelm Beyersdorf, Benny Drieghe, Keith Oldroyd, Geoff Berg, Anders Jeppsson, Kimberly Barber, Kevin Wolschleger, John Heiser, Pim van der Harst, Massimo A. Mariani, Hermann Reichenspurner, Christoffer Stark, Mika Laine, Paul C. Ho, John C. Chen, Richard Zelman, Phillip A. Horwitz, Andrzej Bochenek, Agata Krauze, Christina Grothusen, Dariusz Dudek, George Heyrich, Philippe Kolh, Victor LeGrand, Pedro Coelho, Stephan Ensminger, Boris Nasseri, Richard Ingemansson, Goran Olivecrona, Javier Escaned, Reddy Guera, Sergio Berti, Alaide Chieffo, Nicholas Burke, Michael Mooney, Alvise Spolaor, Christian Hagl, Michael Näbauer, Maarten Jan Suttorp, Ronald A. Stine, Thomas McGarry, Scott Lucas, Knut Endresen, Andrew Taussig, Kevin Accola, Umberto Canosi, Ivan Horvath, Louis Cannon, John D. Talbott, Chris W. Akins, Robert Kramer, Michael Aschermann, William Killinger, Inga Narbute, David R. Holmes, Francesco Burzotta, Ad Bogers, Felix Zijlstra, Helene Eltchaninoff, Jacques Berland, Giulio Stefanini, Ignacio Cruz Gonzalez, Uta Hoppe, Stefan Kiesz, Bartlomiej Gora, Anders Ahlsson, Matthias Corbascio, Thomas Bilfinger, Didier Carrie, Didier Tchétché, Karl-Eugen Hauptman, Elisabeth Stahle, Stefan James, Sigrid Sandner, Günther Laufer, Irene Lang, Adam Witkowski, Vinod Thourani, Harry Suryapranata, Simon Redwood, Charles Knight, Philip MacCarthy, Adam de Belder, Adrian Banning, Anthony Gershlick

Publikováno v: The Lancet (London), 394, 1325-1334
Lancet (UK), 394(10206), 1325-1334. Elsevier Ltd.
The Lancet (London), 394, 10206, pp. 1325-1334

Item does not contain fulltext BACKGROUND: The Synergy between PCI with Taxus and Cardiac Surgery (SYNTAX) trial was a non-inferiority trial that compared percutaneous coronary intervention (PCI) using first-generation paclitaxel-eluting stents with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da31a85919e54f4c2561b4e29279514d
https://pure.eur.nl/en/publications/e5c7ec24-50a5-48a2-9e60-0f133f68ac1b

Long-Term Safety and Efficacy of Platinum Chromium Everolimus-Eluting Stents in Coronary Artery Disease

Autor: Ian T. Meredith, Christophe Dubois, Christopher R. Kelly, Nobuhisa Hagiwara, Shigeru Saito, Vincent Pompili, Paul S. Teirstein, Gregg W. Stone, Dominic Allocco, Alain Bouchard, Bruno Farah, Abram C. Rabinowitz, Didier Carrié, Joseph Dens, Robert L. Feldman, Keith D. Dawkins

Publikováno v: JACC: Cardiovascular Interventions. 10:2392-2400

Objectives The authors sought to evaluate the final 5-year safety and effectiveness of the platinum-chromium everolimus-eluting stent (PtCr-EES) in the randomized trial, as well as in 2 single-arm substudies that evaluated PtCr-EES in small vessels (

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b50a97016bfb3f1a6965e32771a0f4c2
https://doi.org/10.1016/j.jcin.2017.06.070

Safety and efficacy of a bioabsorbable polymer-coated, everolimus-eluting coronary stent in patients with diabetes: the EVOLVE II diabetes substudy

Autor: Arthur Reitman, Ian T. Meredith, Jacques Berland, R. Lee Jobe, Didier Carrié, Dean J. Kereiakes, Mónica Masotti, Juhani Airaksinen, Raul Moreno, Luc Janssens, Andrejs Erglis, Shamir R. Mehta, Bernardo Stein, Thomas Christen, Keith D. Dawkins, Simon Elhadad, Stephan Windecker

Publikováno v: EuroIntervention. 12:1987-1994

AIMS Bioabsorbable polymer drug-eluting stents (DES) may reduce the inflammation and delayed healing associated with some permanent polymer-coated DES. Whether late clinical outcomes are improved, particularly among patients with medically treated di

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10401daecb2d7f9dcde39469961bf9ac
https://doi.org/10.4244/eij-d-16-00643

Repositionable percutaneous aortic valve implantation with the LOTUS valve: 30-day and 1-year outcomes in 250 high-risk surgical patients

Autor: Ted Feldman, Thierry Lefèvre, Didier Tchetche, Dominic J. Allocco, Gilles Rioufol, Ian T. Meredith, David Hildick-Smith, Jan Harnek, Daniel J. Blackman, Nicolas Dumonteil, Thomas Modine, Darren L. Walters, Nicolas M. Van Mieghem, Ganesh Manoharan, Stephen G. Worthley, Keith D. Dawkins

Publikováno v: EuroIntervention
EuroIntervention, EuroPCR, 2017, 13 (7), pp.788-795. ⟨10.4244/eij-d-16-01024⟩
EuroIntervention, 13(7), 788-795. EuroPCR

Aims: The REPRISE IIE trial aimed to evaluate outcomes following transcatheter aortic valve implantation of the fully repositionable and retrievable LOTUS valve with a unique seal designed to minimise paravalvular leak (PVL). Methods and results: Thi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3919b0cdaa59059c75daa6fc551d1bb5
https://doi.org/10.4244/eij-d-16-01024